Recursion Pharmaceuticals(RXRX.US)

Event Tracking

Feb25

Recursion Pharmaceuticals released FY2025 Q4 earnings on February 25 Pre-Market (EST), actual revenue USD 35.54 M (forecast USD 24.56 M), actual EPS USD -0.2071 (forecast USD -0.285)

14:30

Recursion Pharmaceuticals released FY2025 Annual Earnings on February 25 Pre-Market (EST), actual revenue USD 74.68 M (forecast USD 61.61 M), actual EPS USD -1.4409 (forecast USD -1.5853)

14:30

Feb19

ARK Investment Increases Biotech Holdings and Reduces Tech Stocks

05:15

Feb18

Recursion Pharmaceuticals to Release FY2025 Q4 Earnings on February 25, 2026 Pre-Market EST, Forecast Revenue USD 24.56 M, EPS USD -0.285

00:10

Jan23

Christopher Gibson Sells Recursion Pharmaceuticals Inc. Stock

00:35

Jan11

Six Analysts Give Recursion Pharmaceuticals a Hold Rating